Page 4 - Largest Australian (ASX) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Apr 08, 2024

Discover large cap Australian Pharmaceuticals & Biotech companies that are on the ASX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

89 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

NSB

NeuroScientific Biopharmaceuticals
AU$0.06231.9%-23.5%AU$9.0mn/aPE11.8xn/an/a

ZLD

Zelira Therapeutics
AU$0.69-0.7%-30.5%AU$7.9mn/aPS28.3xn/an/a

ILA

Island Pharmaceuticals
AU$0.0658.3%-12.2%AU$7.4mn/aPS7.7xE1.8%n/a

EPN

Epsilon Healthcare
AU$0.0240%20.0%AU$7.2mn/aPB0.8xn/an/a

ANR

Anatara Lifesciences
AU$0.0390%0%AU$6.5mn/aPB5.2xn/an/a

IXC

Invex Therapeutics
AU$0.0850%-81.4%AU$6.4mn/aPS524.7xn/an/a

CGB

Cann Global
AU$0.0210%-72.0%AU$5.4mn/aPS9.7xn/an/a

RGS

Regeneus
AU$0.009n/an/aAU$5.5mn/an/an/an/a

EX1

Exopharm
AU$0.0110%-81.7%AU$4.8mn/aPS1.4xn/an/a

BOD

Bod Science
AU$0.0240%-65.2%AU$4.3mn/aPS1.3xn/an/a

NC6

Nanollose
AU$0.0234.5%-53.1%AU$4.0mn/aPS5.6xn/an/a

ME1

Melodiol Global Health
AU$0.00860.0%-96.0%AU$3.5mn/aPE-0.1xn/an/a

VTL

VGI Health Technology
AU$0.020%n/aAU$2.8mn/aPS112.4xn/an/a

HXL

Hexima
AU$0.01416.7%-6.7%AU$2.3mn/aPS12.1xn/an/a

BP8

BPH Global
AU$0.0010%-80.0%AU$2.0mn/aPE-0.8xn/an/a

RGS

Regeneus
AU$0.013160.0%8.3%AU$1.5mn/aPS4xn/an/a

WFL

Wellfully
AU$0.0030%-87.0%AU$1.5mn/aPE-0.2xn/an/a
Page 4 of 4
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.